GSA Capital Partners’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$546K Buy
+398,237
New +$782K 0.03% 987
2026
Q2
– Sell
-155,869
Closed -$369K – 2051
2026
Q1
$369K Sell
155,869
-35,596
-19% -$123K 0.02% 1113
2025
Q4
$992K Buy
+191,465
New +$928K 0.09% 364
2025
Q3
– Sell
-79,024
Closed -$289K – 1973
2025
Q2
$289K Buy
+79,024
New +$295K 0.02% 1279
2025
Q1
– Sell
-354,154
Closed -$1.13M – 1963
2024
Q4
$1.13M Sell
354,154
-419,393
-54% -$1.41M 0.08% 326
2024
Q3
$2.21M Sell
773,547
-111,174
-13% -$312K 0.17% 96
2024
Q2
$2.48M Buy
884,721
+353,503
+67% +$949K 0.17% 86
2024
Q1
$1.51M Buy
531,218
+269,315
+103% +$915K 0.12% 219
2023
Q4
$1.07M Sell
261,903
-352,665
-57% -$988K 0.09% 356
2023
Q3
$1.95M Sell
614,568
-94,642
-13% -$301K 0.17% 115
2023
Q2
$2.36M Sell
709,210
-16,348
-2% -$48.3K 0.24% 30
2023
Q1
$1.54M Buy
725,558
+522,162
+257% +$1.29M 0.15% 141
2022
Q4
$547K Buy
203,396
+191,407
+1,597% +$558K 0.07% 548
2022
Q3
$39K Sell
11,989
-22,391
-65% -$101K 0.01% 1435
2022
Q2
$168K Buy
34,380
+21,530
+168% +$133K 0.03% 1114
2022
Q1
$98K Buy
+12,850
New +$99.5K 0.01% 1297
2020
Q4
– Sell
-16,953
Closed -$65K – 1499
2020
Q3
$65K Buy
+16,953
New +$66.9K 0.01% 1170

Other funds holding ORGO

GSA Capital Partners's ORGO Position: Q3 2026 in Review

GSA Capital Partners opened a new position in Organogenesis Holdings (ORGO) in Q3 2026: 398,237 shares worth $546K. The stake represents 0.03% of the portfolio and ranks #987 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in ORGO as recently as Q1 2026.

GSA Capital Partners first reported a position in ORGO in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.48M in Q2 2024. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

  • GSA Capital Partners held 398,237 shares of Organogenesis Holdings worth $546K as of Q3 2026.
  • Organogenesis Holdings was a new GSA Capital Partners position in Q3 2026.
  • Organogenesis Holdings made up 0.03% of GSA Capital Partners's portfolio in Q3 2026, its #987 holding.
  • GSA Capital Partners first reported a position in Organogenesis Holdings in Q3 2020 and has held it in 17 quarters since.
  • GSA Capital Partners's Organogenesis Holdings position peaked at $2.48M in Q2 2024.
  • 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.